Quick Answer
Cogent Biosciences, Inc. reported Earnings Per Share Diluted of $2.16 (loss) per share for the year ending 2025.
- Cogent Biosciences, Inc. showed a decrease of -11.3% in Earnings Per Share Diluted from 2024 to 2025.
- This data is from Cogent Biosciences, Inc.'s annual report (Form 10-K), filed with the SEC on February 17, 2026.
- XBRL data for this metric is available from 2021 to 2025 (5 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 5 years of available data (2021 to 2025), Cogent Biosciences, Inc.'s Earnings Per Share Diluted has declined by 15.5%.
- Historical annual values: Fiscal year 2025: $2.16 (loss) per share | Fiscal year 2024: $1.94 (loss) per share | Fiscal year 2023: $1.94 (loss) per share | Fiscal year 2022: $1.73 (loss) per share | Fiscal year 2021: $1.87 (loss) per share.
- Data sourced from SEC EDGAR public filings as of June 22, 2026.
Last verified: